Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Muniyappa, Ranganath ^a   Xu, Rui ^a   Ram, Jeffrey L ^a   Sowers, James R ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Guanosine 5' triphosphate phosphohydrolase; Inducible; Nitric oxide synthase

Indexed keywords

BOTULINUM TOXIN; CITRULLINE; CLOSTRIDIUM DIFFICILE TOXIN B; COMPACTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE SYNTHASE; RAS PROTEIN; RHO FACTOR;

ANIMAL CELL; ARTERY INJURY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ISOPRENYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0033935251     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.6.h1762     Document Type: Article

References (49)

1. Adamson P, Marshall CJ, Hall A, and Tilbrook PA. Post-translational modifications of p21rho proteins. J Biol Chem 267: 20033-20038, 1992.
2. Aktories K. Rho proteins: targets for bacterial toxins. Trends Microbiol 5: 282-288, 1997.
3. Aktories K. Bacterial toxins that target Rho proteins. J Clin Invest 99: 827-829, 1997.
4. Boyde TR and Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal Biochem 107:424-431, 1980.
5. Diaz-Guerra MJ, Castrillo A, Martin-Sanz P, and Bosca L. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. J lmmunol 162: 6184-6190, 1999.
6. Dillon ST, Rubin EJ, Yakubovich M, Pothoulakis C, LaMont JT, Feig LA, and Gilbert RJ. Involvement of Ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun 63: 1421-1426, 1995.
7. Finder JD, Litz JL, Blaskovich MA, McGuire TF, Qian Y, Hamilton AD, Davies P, and Sebti SM. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1 beta in vascular smooth muscle cells. J Biol Chem 272: 13484-13488, 1997.
8. Fukumoto Y, Shimokawa H, Kozai T, Kadokami T, Kuwata K, Yonemitsu Y, Kuga T, Egashira K, Sueishi K, and Takeshita A. Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1beta in pigs in vivo. Circulation 96: 3104-3111, 1997.
9. Ghosh PM, Mott GE, Ghosh-Choudhoury N, Radnik RA, Stapleton ML, Ghidoni JJ, and Kreisburg JL. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim Biophys Acta 1359: 13-24, 1997.
10. Glomset JA and Farnsworth CC. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu Rev Cell Biol 10: 181-205, 1994.
11. Goldstein JL, Helgeson JA, and Brown MS. Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor. J Biol Chem 254: 5403-5409, 1979.
12. 15N] in biological fluids. Anal Biochem 126: 131-138, 1982.
13. Guan Z, Baier LD, and Morrison AR. p38 Mitogen-activated protein kinase down-regulates nitric oxide and up-regulates prostaglandin E2 biosynthesis stimulated by interleukin-1β. J Biol Chem 272: 8083-8089, 1997.
14. Hall A. Signal transduction pathways regulated by the Rho family of small GTPases. Br J Cancer 80: 25-27, 1999.
15. Hippenstiel S, Tannert-Otto S, Vollrath N, Krull M, Just I, Aktories K, Von Eichel-Streiber, C, and Suttorp N. Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 272: L38-L43, 1997.
16. Joly GA, Schini VB, and Vanhoutte PM. Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries. Circ Res 71: 331-338, 1998.
17. Just I, Selzer J, Wilm M, Von Eichel-Streiber C, Mann M, and Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375: 500-503, 1995.
18. Kanno K, Hirata Y, Imai T, and Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension 22: 34-39, 1993.
19. Kaziro Y, Itoh H, Kozasa T, Nakafuku M, and Satoh T. Structure and function of signal-transducing GTP-binding proteins. Annu Rev Biochem 60: 349-400, 1991.
20. Kita T, Brown MS, and Goldstein JL. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest 66: 1094-1100, 1980.
21. Koch G, Benz C, Schmidt G, Olenik C, and Aktories K. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther 283: 901-909, 1997.
22. Koglin J, Glysing-Jensen T, Mudgett JS, and Russell ME. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 97: 2059-2065, 1998.
23. Laufs U and Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273: 24266-24271, 1998.
24. Mackay DJG and Hall A. Rho GTPases. J Biol Chem 273: 20685-20688, 1998.
25. Malcolm KC, Elliott CM, and Exton JH. Evidence for Rhomediated agonist stimulation of phospholipase D in rat 1 fibroblasts. Effects of Clostridium botulinium C3 exoenzyme. J Biol Chem 271: 13135-13139, 1996.
26. Marczin N, Jilling T, Papapetropoulos A, Go C, and Catravas JD. Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells. Br J Pharmacol 118: 1085-1094, 1996.
27. Marshall CJ and Leevers SJ. Mitogen-activated protein kinase activation by scrape loading p21ras. Methods Enzymol 255: 273-279, 1995.
28. Michel T and Feron O. Nitric oxide synthases: which, where, how, and why? J Clin Invest 100: 2146-2152, 1997.
29. Montaner S, Perona R, Saniger L, and Lacal JC. Multiple Signaling pathways lead to the activation of the nuclear factor κB by the Rho family of GTPases. J Biol Chem 273: 12779-12785, 1998.
30. Moores SL, Schaber MD, Mosser SD, Rand E, O'Hara MB, Garsky VM, Marshall MS, Pompliano DL, and Gibbs JB. Sequence dependence of protein isoprenylation. J Biol Chem 266: 14603-14610, 1991.
31. Muniyappa R, Srinivas PR, Ram JL, Walsh MF, and Sowers JR. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 31: 289-295, 1998.
32. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100: 2417-2423, 1997.
33. Park HJ and Galper JB. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylger-anylation of RhoA GTPase. Proc Natl Acad Sci USA 96: 11525-11530, 1999.
34. Perella MA, Patterson C, Tan L, Yet SF, Hsieh CM, Yoshizumi M, and Lee ME. Supression of interleukin-1β-induced nitric oxide synthase promoter/enhancer activity by transforming growth factor β1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-κB J Biol Chem, 271: 13776-13780, 1996.
35. Rikitake Y, Hirata K, Kawashima S, Akita H, and Yokoyama M. Inhibitory effect of inducible type nitric oxide synthase on oxidative modification of low density lipoprotein by vascular smooth muscle cells. Atherosclerosis 136: 51-57, 1998.
36. Rosenson RS and Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279: 1643-1650, 1998.
37. Schreck R, Meier B, Mannel DN, Droge W, and Baeuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med 175: 1181-1194, 1992.
38. Sehr P, Joseph G, Genth H, Just I, Pick E, and Aktories K. Glucosylation and ADP ribosylation of rho proteins: effects on nucleotide binding, GTPase activity, and effector coupling. Biochemistry 37: 5296-5304, 1998.
39. Singh K, Balligand JL, Fischer TA, Smith TW, and Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STATIα. J Biol Chem 271: 1111-1117, 1996.
40. Singh R, Huang S, Guth T, Konieczkowski M, and Sedor JR. Cytosolic domain of the type I interleukin-1 receptor spontaneously recruits signaling molecules to activate a proinflammatory gene. J Clin Invest 100:419-428, 1997.
41. Singh R, Wang B, Shirvaikar A, Khan S, Kamat S, Schelling JR, Konieczkowski M, and Sedor JR. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 103: 1561-1570, 1999.
42. Sizemore N, Leung S, and Stark GR. Activation of phosphati-dylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol 19: 4798-4805, 1999.
43. +-ATPase in rat arterial smooth muscle. Am J Physiol Endocrinol Metab 273: E113-E121, 1997.
44. Stark WW, Blaskovich MA, Johnson BA, Qian Y, Vasudevan A, Pitt B, Hamilton AD, Sebti SM, and Davies P. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 275: L55-L63, 1998.
45. Thorburn J, Xu S, and Thorburn A. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J 16: 1888-1900, 1997.
46. Whitmarsh AJ, Shore P, Sharrocks AD, and Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407, 1995.
47. Wong HR, Finder JD, Wasserloos K, Lowenstein CJ, Geller DA, Billiar TR, Pitt BR, and Davies P. Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 271: L166-L171, 1996.
48. Yan Z and Hansson GK. Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells. Circ Res 82: 21-29, 1998.
49. Yan ZQ, Yokota T, Zhang W, and Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 79: 38-44, 1996.